Gary H. Lyman MD, MPH, is a Member of the Public Health Sciences and Clinical Research Divisions at the Fred Hutchinson Cancer Research Center, USA. He is also Professor of Medicine in the University of Washington School of Medicine, USA, as well as Adjunct Professor in the Schools of Public Health and Pharmacy at the University of Washington, USA.
Dr Lyman’s research interests include precision medicine based on personalized cancer treatment and supportive care, comparative effectiveness and outcomes research related to biomarkers and targeted therapies, mathematical and statistical prognostic and predictive models, advanced methods of evidence synthesis in support of clinical practice guidelines and population studies of patterns of cancer treatment and the impact of health disparities on the quality of cancer care. Dr Lyman has authored or edited more than 15 books and more than 600 articles in the scientific literature.
Dr Lyman continues to serve prominent roles within ASCO, AACR and ASH. He is also active with SWOG serving as Executive Office for the SWOG NCORP and the Immunotherapy, Symptom Management and Quality of Life, Cancer Care Delivery Research, and Palliative Care Committees and is on the Board of Directors of the Hope Foundation. Dr Lyman is Editor-In-Chief of Cancer Investigation and on the Editorial Board of the Journal of Clinical Oncology, the Journal of Global Oncology and several other specialty journals.